PRIOR AUTHORIZATION POLICY Tecfidera® (dimethyl fumarate delayed-release capsules Biogen Idec) To Initiate a Coverage Review, Call[removed] - Delayed release - Document - PDFSEARCH.IO

First Page	Meta Content
	PRIOR AUTHORIZATION POLICY Tecfidera® (dimethyl fumarate delayed-release capsules Biogen Idec) To Initiate a Coverage Review, Call[removed] Add to Reading List Document Date: 2014-01-29 12:47:07 Open Document File Size: 164,77 KB Share Result on Facebook City Cambridge / / Company Biogen Idec Inc / AEs / / Event FDA Phase / Person Communication and Meetings / / IndustryTerm treatment of MS / healthcare / food / / MedicalCondition abdominal pain / MS Disease / multiple sclerosis / flushing / diarrhea / MS / nausea / secondary-progressive multiple sclerosis / / Organization Administration of Tecfidera / National Multiple Sclerosis Society / National MS Society / Food and Drug Administration / National Clinical Advisory Board / / / Position physician / neurologist / / Product Copaxone / Tysabri / Rebif / Betaseron / Avonex / BG / / ProvinceOrState Mississippi / / URL http / SocialTag Medicine Immunosuppressants Autoimmune diseases Cytokines Treatment of multiple sclerosis Glatiramer acetate Interferon beta-1a Natalizumab Biogen Idec Immunology

PRIOR AUTHORIZATION POLICY Tecfidera® (dimethyl fumarate delayed-release capsules Biogen Idec) To Initiate a Coverage Review, Call[removed]Add to Reading List